Rwanda FDA Rolls Out New Guidelines to Ensure Fair Pricing of Medicines

The guidelines apply to all players in the pharmaceutical supply chain—importers, wholesalers, distributors, and retailers—operating in both public and private healthcare facilities across the country. They introduce a clear structure for both general and regressive mark-ups, setting the stage for a more accountable and transparent pharmaceutical market.

According to Rwanda FDA, the new system is designed to achieve four critical goals: promoting fair and transparent pricing practices, ensuring the affordability and accessibility of essential medical products, strengthening cost-containment measures, and boosting public trust in the availability and pricing of medicines.

This step reflects Rwanda’s continued commitment to building a sustainable healthcare system where no citizen is denied access to essential medicines due to cost barriers. By balancing the needs of suppliers and the rights of patients, the Rwanda FDA’s regulatory intervention is expected to bring lasting benefits to both the health sector and the broader public.